A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients

A. Colao, R. Pivonello, L. Spinelli, M. Galderisi, R. S. Auriemma, M. Galdiero, G. Vitale, M. De Leo, G. Lombardi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This analytical, observational, retrospective, case-control study was designed to describe clinical presentation, biochemical disease severity, presence, and severity of metabolic and cardiovascular complications in patients diagnosed as having acromegaly at 60 yr or older (no.=57) as compared to sex- and age-matched healthy controls. Patients and controls underwent a complete endocrine, metabolic, and cardiovascular check-up. The age at diagnosis was equally distributed between 60 to 75 yr while only a minority of the patients (5.3%) was diagnosed after 75 yr. Median GH and IGF-I levels were 15 μg/l and 557 μg/l. The prevalence of microadenomas, enclosed macroadenomas, and extrasellar/invasive macroadenomas was 30%, 49%, and 21%, respectively. All patients had joint complaints and goiter (euthyroid in 65% and pre-toxic/toxic in 35%), 82% had hypertension, 58% diabetes and 54% had both. As compared to controls, a higher number of patients were receiving treatment with anti-arrhythmiacs (p=0.033), anti-aggregants (p=0.013), levothyroxine (p=0.015), and metformin (p=0.022). Nevertheless, the patients had higher systolic and diastolic blood pressure, heart rate, left ventricular mass index, lipids, glucose and insulin levels as well as percent function of β cells than controls. In conclusion, the high prevalence of systemic complications makes elderly acromegalics more susceptible than controls to cardiovascular events. We suggest that an accurate clinical check-up and, possibly, a more aggressive treatment of hypertension and diabetes are required in elderly acromegalics.

Original languageEnglish
Pages (from-to)497-506
Number of pages10
JournalJournal of Endocrinological Investigation
Volume30
Issue number6
Publication statusPublished - Jun 2007

Fingerprint

Cardiomyopathies
Poisons
Blood Pressure
Hypertension
Acromegaly
Metformin
Insulin-Like Growth Factor I
Thyroxine
Case-Control Studies
Joints
Heart Rate
Insulin
Lipids
Glucose
Therapeutics

Keywords

  • Acromegaly
  • Cardiomyopathy
  • GH
  • IGF-I
  • Lanreotide
  • Octreotide
  • Somatostatin
  • Surgery

ASJC Scopus subject areas

  • Endocrinology

Cite this

Colao, A., Pivonello, R., Spinelli, L., Galderisi, M., Auriemma, R. S., Galdiero, M., ... Lombardi, G. (2007). A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. Journal of Endocrinological Investigation, 30(6), 497-506.

A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. / Colao, A.; Pivonello, R.; Spinelli, L.; Galderisi, M.; Auriemma, R. S.; Galdiero, M.; Vitale, G.; De Leo, M.; Lombardi, G.

In: Journal of Endocrinological Investigation, Vol. 30, No. 6, 06.2007, p. 497-506.

Research output: Contribution to journalArticle

Colao, A, Pivonello, R, Spinelli, L, Galderisi, M, Auriemma, RS, Galdiero, M, Vitale, G, De Leo, M & Lombardi, G 2007, 'A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients', Journal of Endocrinological Investigation, vol. 30, no. 6, pp. 497-506.
Colao, A. ; Pivonello, R. ; Spinelli, L. ; Galderisi, M. ; Auriemma, R. S. ; Galdiero, M. ; Vitale, G. ; De Leo, M. ; Lombardi, G. / A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. In: Journal of Endocrinological Investigation. 2007 ; Vol. 30, No. 6. pp. 497-506.
@article{a7f9084290db4cf0a79775acfdbe75f2,
title = "A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients",
abstract = "This analytical, observational, retrospective, case-control study was designed to describe clinical presentation, biochemical disease severity, presence, and severity of metabolic and cardiovascular complications in patients diagnosed as having acromegaly at 60 yr or older (no.=57) as compared to sex- and age-matched healthy controls. Patients and controls underwent a complete endocrine, metabolic, and cardiovascular check-up. The age at diagnosis was equally distributed between 60 to 75 yr while only a minority of the patients (5.3{\%}) was diagnosed after 75 yr. Median GH and IGF-I levels were 15 μg/l and 557 μg/l. The prevalence of microadenomas, enclosed macroadenomas, and extrasellar/invasive macroadenomas was 30{\%}, 49{\%}, and 21{\%}, respectively. All patients had joint complaints and goiter (euthyroid in 65{\%} and pre-toxic/toxic in 35{\%}), 82{\%} had hypertension, 58{\%} diabetes and 54{\%} had both. As compared to controls, a higher number of patients were receiving treatment with anti-arrhythmiacs (p=0.033), anti-aggregants (p=0.013), levothyroxine (p=0.015), and metformin (p=0.022). Nevertheless, the patients had higher systolic and diastolic blood pressure, heart rate, left ventricular mass index, lipids, glucose and insulin levels as well as percent function of β cells than controls. In conclusion, the high prevalence of systemic complications makes elderly acromegalics more susceptible than controls to cardiovascular events. We suggest that an accurate clinical check-up and, possibly, a more aggressive treatment of hypertension and diabetes are required in elderly acromegalics.",
keywords = "Acromegaly, Cardiomyopathy, GH, IGF-I, Lanreotide, Octreotide, Somatostatin, Surgery",
author = "A. Colao and R. Pivonello and L. Spinelli and M. Galderisi and Auriemma, {R. S.} and M. Galdiero and G. Vitale and {De Leo}, M. and G. Lombardi",
year = "2007",
month = "6",
language = "English",
volume = "30",
pages = "497--506",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "6",

}

TY - JOUR

T1 - A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients

AU - Colao, A.

AU - Pivonello, R.

AU - Spinelli, L.

AU - Galderisi, M.

AU - Auriemma, R. S.

AU - Galdiero, M.

AU - Vitale, G.

AU - De Leo, M.

AU - Lombardi, G.

PY - 2007/6

Y1 - 2007/6

N2 - This analytical, observational, retrospective, case-control study was designed to describe clinical presentation, biochemical disease severity, presence, and severity of metabolic and cardiovascular complications in patients diagnosed as having acromegaly at 60 yr or older (no.=57) as compared to sex- and age-matched healthy controls. Patients and controls underwent a complete endocrine, metabolic, and cardiovascular check-up. The age at diagnosis was equally distributed between 60 to 75 yr while only a minority of the patients (5.3%) was diagnosed after 75 yr. Median GH and IGF-I levels were 15 μg/l and 557 μg/l. The prevalence of microadenomas, enclosed macroadenomas, and extrasellar/invasive macroadenomas was 30%, 49%, and 21%, respectively. All patients had joint complaints and goiter (euthyroid in 65% and pre-toxic/toxic in 35%), 82% had hypertension, 58% diabetes and 54% had both. As compared to controls, a higher number of patients were receiving treatment with anti-arrhythmiacs (p=0.033), anti-aggregants (p=0.013), levothyroxine (p=0.015), and metformin (p=0.022). Nevertheless, the patients had higher systolic and diastolic blood pressure, heart rate, left ventricular mass index, lipids, glucose and insulin levels as well as percent function of β cells than controls. In conclusion, the high prevalence of systemic complications makes elderly acromegalics more susceptible than controls to cardiovascular events. We suggest that an accurate clinical check-up and, possibly, a more aggressive treatment of hypertension and diabetes are required in elderly acromegalics.

AB - This analytical, observational, retrospective, case-control study was designed to describe clinical presentation, biochemical disease severity, presence, and severity of metabolic and cardiovascular complications in patients diagnosed as having acromegaly at 60 yr or older (no.=57) as compared to sex- and age-matched healthy controls. Patients and controls underwent a complete endocrine, metabolic, and cardiovascular check-up. The age at diagnosis was equally distributed between 60 to 75 yr while only a minority of the patients (5.3%) was diagnosed after 75 yr. Median GH and IGF-I levels were 15 μg/l and 557 μg/l. The prevalence of microadenomas, enclosed macroadenomas, and extrasellar/invasive macroadenomas was 30%, 49%, and 21%, respectively. All patients had joint complaints and goiter (euthyroid in 65% and pre-toxic/toxic in 35%), 82% had hypertension, 58% diabetes and 54% had both. As compared to controls, a higher number of patients were receiving treatment with anti-arrhythmiacs (p=0.033), anti-aggregants (p=0.013), levothyroxine (p=0.015), and metformin (p=0.022). Nevertheless, the patients had higher systolic and diastolic blood pressure, heart rate, left ventricular mass index, lipids, glucose and insulin levels as well as percent function of β cells than controls. In conclusion, the high prevalence of systemic complications makes elderly acromegalics more susceptible than controls to cardiovascular events. We suggest that an accurate clinical check-up and, possibly, a more aggressive treatment of hypertension and diabetes are required in elderly acromegalics.

KW - Acromegaly

KW - Cardiomyopathy

KW - GH

KW - IGF-I

KW - Lanreotide

KW - Octreotide

KW - Somatostatin

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=34848813144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848813144&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 497

EP - 506

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 6

ER -